Mitokinin Revenue and Competitors
Estimated Revenue & Valuation
- Mitokinin's estimated annual revenue is currently $2.6M per year.
- Mitokinin's estimated revenue per employee is $155,000
Employee Data
- Mitokinin has 17 Employees.
- Mitokinin grew their employee count by -35% last year.
Mitokinin's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Translational Medicine | Reveal Email/Phone |
2 | Director, Cell Biology | Reveal Email/Phone |
3 | Director, Biomarkers | Reveal Email/Phone |
4 | Senior Scientist | Reveal Email/Phone |
5 | Research Associate | Reveal Email/Phone |
6 | Principal Scientist | Reveal Email/Phone |
7 | Research Associate | Reveal Email/Phone |
8 | Research Associate | Reveal Email/Phone |
Mitokinin Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Mitokinin?
Mitokinin has advanced small molecule therapeutics that specifically increase the activity of active-form PINK1. Importantly, Mitokinin's compounds do not interfere with the endogenous regulation of PINK1. PINK1 is a master regulator of mitochondrial quality control. Mutations in PINK1 give rise to familial forms of Parkinson's disease. Increased PINK1 activity rescues pathologies associated with neurodegenerative disease. Mitokinin has an accomplished team of neuroscientists, chemists, pharmacologists, and administrative professionals all focused on our mission: delivering disease-modifying therapies for neurodegenerative disease.
keywords:N/A
N/A
Total Funding
17
Number of Employees
$2.6M
Revenue (est)
-35%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Mitokinin News
In March 2021 it agreed to buy Mitokinin and its PINK1 clinical programme for the potential treatment of Parkinson's disease for an...
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.3M | 17 | -15% | $38.3M |
#2 | $1.3M | 17 | -43% | $37.8M |
#3 | $2.6M | 17 | 0% | N/A |
#4 | $1.5M | 17 | -11% | N/A |
#5 | $0.5M | 17 | -23% | $42.5M |